Nuwan Kurukulasuriya

Statistics

Publications

Citations

514

H-Index

Active since

2003

Affiliations

Biogen (United States)(Current)

St. Josef-Hospital

Cleveland Clinic

University of Alberta

Asan Medical Center

Nuwan Kurukulasuriya is an author at Biogen (United States) specializing in pharmacotherapy, medicine, and relapsing-remitting multiple sclerosis treatment.

Publications per year

2003–2023

Publications

Long-term effects of delayed-release dimethyl fumarate in multiple sclerosis: Interim analysis of ENDORSE, a randomized extension study

Ralf Gold, Douglas L. Arnold, Amit Bar‐Or et al. · Multiple Sclerosis Journal · 2016 · 151 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Delayed-Release Dimethyl Fumarate and Pregnancy: Preclinical Studies and Pregnancy Outcomes from Clinical Trials and Postmarketing Experience

Ralf Gold, J. Theodore Phillips, Eva Havrdová et al. · Neurology and Therapy · 2015 · 99 citations · Full text

Medicine, Obstetrics, Pharmacotherapy +13

Efficacy and safety of delayed-release dimethyl fumarate in patients newly diagnosed with relapsing–remitting multiple sclerosis (RRMS)

Ralf Gold, Gavin Giovannoni, J. Theodore Phillips et al. · Multiple Sclerosis Journal · 2014 · 64 citations · Full text

Pharmacy, Neurology, Pharmacotherapy +15

Effect of Aspirin Pretreatment or Slow Dose Titration on Flushing and Gastrointestinal Events in Healthy Volunteers Receiving Delayed-release Dimethyl Fumarate

John O’Gorman, Heidy K. Russell, Jie Li et al. · Clinical Therapeutics · 2015 · 38 citations

Pharmacy, Pharmacology, Pharmacotherapy +6

Cladribine tablets for relapsing–remitting multiple sclerosis: Efficacy across patient subgroups from the phase III CLARITY study

Kottil Rammohan, Gavin Giovannoni, Stuart D. Cook et al. · Multiple Sclerosis and Related Disorders · 2011 · 34 citations

Medicine, Neurology, Pharmacology +8

1–5 of 10